* Axonics Inc AXNX.OQ AXNX.O is expected to show a rise
in
quarterly revenue when it reports results on October 31.
* The Irvine California-based company is expected to report
a
34.2% increase in revenue to $62.976 million from $46.91 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Axonics Inc is for
a loss
of 48 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Axonics Inc
is
$84, above its last closing price of $71.90.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.54 -0.54 -0.47 Beat 13.4
Mar. 31 2022 -0.65 -0.63 -0.50 Beat 21
Dec. 31 2021 -0.37 -0.37 -0.34 Beat 8.1
Sep. 30 2021 -0.43 -0.43 -0.38 Beat 11.9
Jun. -0.48 -0.49 -0.59 Missed -20.2
30 2021
Mar. 31 2021 -0.41 -0.41 -0.46 Missed -12.7
Dec. 31 2020 -0.31 -0.31 -0.29 Beat 6.1
Sep. 30 2020 -0.51 -0.50 -0.24 Beat 52.1
This summary was machine generated October 29 at 02:10 GMT. All
figures in US dollars unless otherwise stated